FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 309:625-629 September 15, 1983 Number 11 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We measured the complement-dependent cytotoxic activity of serum in 60 patients with pernicious anemia. Canine gastric mucosal cells served as the indicator of cytotoxicity, which was expressed as a percentage of the maximal effect produced by a cytolytic agent (Triton X-100). Serum from patients with pernicious anemia showed a higher average activity (11.8 +/- 10.3 per cent, P less than 0.001) than serum from 29 patients with systemic lupus erythematosus (1.0 +/- 1.8 per cent), 10 with scleroderma (0.1 +/- 0.1 per cent), 10 with rheumatoid arthritis (0.6 +/- 0.6 per cent), 22 with multiple sclerosis (0.4 +/- 1.2 per cent), and 23 with chronic persistent hepatitis (0.03 +/- 0.1 per cent), and serum from 64 healthy persons (0.4 +/- 1.0 per cent). Serum from patients with pernicious anemia was not toxic to canine liver or kidney cells. Absorption with gastric mucosal cells and heat inactivation of complement abolished the cytotoxic reaction. The cytotoxic factor resided in the IgG fraction of immunoglobulin, and the amount of cytotoxicity was proportional to the IgG concentration. Cytotoxic activity correlated with the presence of parietal-cell-surface--reactive autoantibody demonstrated by immunofluorescence. We conclude that cytotoxic autoantibodies to parietal cells may contribute to the loss of such cells from the gastric mucosa of patients with pernicious anemia.

This article has been cited by other articles:

• Carpenter, C. L., Patalas, E. D. (2000). Case 40-2000- A 38-Year-Old Woman with Gastric Adenocarcinoma. NEJM 343: 1951-1958 [Full Text]  
• Snow, C. F. (1999). Laboratory Diagnosis of Vitamin B12 and Folate Deficiency: A Guide for the Primary Care Physician. Arch Intern Med 159: 1289-1298 [Abstract] [Full Text]  
• Toh, B.-H., van Driel, I. R., Gleeson, P. A. (1997). Pernicious Anemia. NEJM 337: 1441-1448 [Full Text]  
• Bose, S., Komorowski, R., Seetharam, S., Gilfix, B., Rosenblatt, D. S., Seetharam, B. (1996). In Vitro and in Vivo Inactivation of Transcobalamin II Receptor by Its Antiserum. J. Biol. Chem. 271: 4195-4200 [Abstract] [Full Text]  
• Talley, N. J., Chute, C. G., Larson, D. E., Epstein, R., Lydick, E. G., Melton, L. J. III (1989). Risk for Colorectal Adenocarcinoma in Pernicious Anemia: A Population-Based Cohort Study. ANN INTERN MED 111: 738-742 [Abstract]